Delivery Order SPE2DB22D7058-SPE2DB24FSXB8

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,555,991 units of Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $1,637.96 with a completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.84, is for the delivery of 4,567,362,662 units of Meloxicam 15 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. The award is not designated as a Set-Aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,023.67 fixed-price contract is for the delivery of 4,566,613,832 units of the medication meloxicam 15 mg tablets. The award has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,853.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 7.5 mg tablets in 90-count packages. This appears to be a firm-fixed-price delivery order contract, with an ultimate completion date of April 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,732.57, is for the delivery of 4,566,998,671 units of Meloxicam 15 mg tablets. The contract has a period of performance through January 22, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVJ26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,415.00 firm fixed-price delivery order is for 4,567,983,177 units of the medication Meloxicam 15 mg Tablet. The contract has an ultimate completion date of April 22, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,419.24 firm fixed-price delivery order is for the supply of 4,566,661,486 units of the prescription medication Meloxicam 15 mg tablet. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,222.56 firm fixed price delivery order is for the supply of 180 tablets of the medication Meloxicam 15 mg. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential...
This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB24FSXB8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,244,803 units of the medication Meloxicam 7.5 mg tablets. The contract, valued at $1,266.60, has a completion date of July 26, 2024. This is a delivery order contract for the firm-fixed-price supply of this pharmaceutical product. The award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) by various defense and civilian agencies, including the DLA and the Department of Justice, to provide a wide range of critical medical commodities, pharmaceuticals, and medical supplies to support government healthcare programs and facilities.

Generated 10/27/24, 4:31 AM